In Russia, clinical trials of the Enteromix Oncaches began

Our institute is the first who is entrusted with an open, one -center clinical study of the first phase with the participation of this vaccine. It has already begun, 48 volunteers have been typed, the toxic effect, in general, is very insignificant— said Andrei Caprine as part of the session “Development of personalized oncological drugs: the future today” at the PMEF.

He previously stated that cancer patients would be able to Get free Cancer vaccine developed in Russia.

The Russian vaccine from cancer is developed jointly by several scientific teams — the center named after Gamaley, Moscow Research Oncological Institute. P.A. Herzen and NMIC oncology named after N.N. Blokhina. The work on the development of the vaccine is financed by the state. Preclinic tests of the drug are completedThe head of the Federal Biological Agency (FMBA) Veronika Skvortsova said in November.

In early December 2024, the director of the NIC of epidemiology and microbiology named after Gamaley Alexander Ginzburg told RIA Novosti Crimea that The new Russian cancer vaccine has shown its effectivenessit will begin to be used for patients in the fall of next year. At first, such high-tech assistance will be available on the basis of two leading cancer centers of the country-the Moscow Scientific Research Institute named after Herzen and the NMIC of the Blokhin Oncology.

source: RIA Novosti Crimea